Bausch Health Companies Inc. Common Stock (BHC)

CEO highlights $1B EBITDA milestone and $521M debt reduction.

Bausch Health Cos (NYSE:BHC) raised its full-year 2026 outlook for the second consecutive quarter after reporting third-quarter growth across its operating segments, led by Salix and supported by international operations and Solta Medical. Excluding Bausch + Lomb, Bausch Health reported third-quart

Much of this was due to a very well-received quarterly earnings report.

Xifaxan surged 26% and Solta margins expanded sharply on strong growth.

Bausch Health Cos (NYSE:BHC) reported second-quarter results that management said extended its streak of revenue and adjusted EBITDA growth to 13 consecutive quarters, driven by performance in its Salix, international and Solta Medical businesses. For Bausch Health excluding Bausch + Lomb, second-q

Investors liked what they saw with the company's opening 2026 earnings report.

Bausch Health (BHC) Q1 2026 Earnings Transcript

Bausch Health (BHC) Q3 2024 Earnings Transcript

Bausch Health (BHC) Q4 2025 Earnings Transcript

Bausch Health's turnaround could pay off for value investors patient enough to wait for it.

Bausch Health’s valuation suggests potential, but the stake cut shows how far the company still has to go to earn back full investor confidence.

Investors were obviously impressed with the company's latest acquisition.

Markets gave up ground to start the new month.

Carl Icahn's hedge fund Q3 portfolio reshuffle: $9.14B, concentrated, contrarian. Walked away from Bausch Health, added EchoStar.

Carl Icahn's empire, IEP, has collapsed 80% due to Hindenburg's short-selling attack. Icahn's net worth is down 75%.

Bausch Health (BHC) Q3 2025 Earnings Transcript

Corporate insiders, often privy to the most granular details of their companies' health and future prospects, have been sending a clear signal to the market over the past 12-18 months: caution. A significant surge in insider selling, particularly pronounced in 2025, has overshadowed buying activity, pushing the U.S. market

Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites.

John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet.